Use fundamental data analysis to validate all available fundamentals of Globus Medical to find out if markets are presently mispricing the organization. We found thirty-four available reported financial drivers for Globus Medical which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Globus Medical fundamentals including its Net Income, Cash Flow from Operations and the relationship between Revenue and Debt to Equity . Given that Globus Medical has Number of Shares Shorted of 2.83M, we strongly advise you confirm Globus Medical regular market performance to make sure the company can sustain itself down the road. Use Globus Medical to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Globus Medical to be traded at $47.14 in 30 days.
Globus Medical Company Summary
Globus Medical competes with Establishment Labs. Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 1500 people.
Globus Medical Short Ratio vs Price to Earnings To Growth
Globus Medical is rated # 2 in short ratio category among related companies. It is one of the top stocks in price to earnings to growth category among related companies producing about 0.74 of Price to Earnings To Growth per Short Ratio. The ratio of Short Ratio to Price to Earnings To Growth for Globus Medical is roughly 1.36
|Short Ratio ( times )|
|Price to Earnings To Growth ( times )|
Globus Medical Systematic Risk